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a b s t r a c t
Histamine is a neurotransmitter and chemical mediator in multiple physiological processes. Histamine
H3 receptor is expressed in the nervous system, heart, and gastrointestinal tract; however, little is known
about H3 receptor in skeletal muscle. The aim of this study was to investigate the role of H3 receptor in
skeletal myotubes. The expression of H3 receptor and myosin heavy chain (MHC), a late myogenesis
marker, was assessed by real-time PCR and immunostaining in C2C12 skeletal myogenesis and adult
mid-urethral skeletal muscle tissues. H3 receptor mRNA showed a significant increase upon differentia-
tion of C2C12 into myotubes: 1-, 26-, 91-, and 182-fold at days 0, 2, 4, and 6, respectively. H3 receptor
immunostaining in differentiated C2C12 cells and adult skeletal muscles was positive and correlated
with that of MHC. The functional role of H3receptor in differentiated myotubes was assessed using an H3
receptor agonist, (R)-a-methylhistamine ((R)-α-MeHA). Ca2þ imaging, stimulated by electric pacing, was
decreased by 55% after the treatment of mature C2C12 myotubes with 1 μM (R)-α-MeHA for 10 min and
20 min, while treatment with 100 nm (R)-α-MeHA for 5 min caused 45% inhibition. These results
suggested that H3 receptor may participate in the maintenance of the relaxed state and prevention of
over-contraction in mature differentiated myotubes. The elucidation of the role of H3R in skeletal
myogenesis and adult skeletal muscle may open a new direction in the treatment of skeletal muscle
disorders, such as muscle weakness, atrophy, and myotonia in motion systems or peri-urethral skeletal
muscle tissues.
& 2015 Elsevier B.V. All rights reserved.
1. Introduction
Histamine is a well-known biogenic cationic amine that is
synthesized, stored, and released by professional histamine-
synthesizing cells, such as mast cells, basophils, and enterochro-
maffin cells. These cells express histidine decarboxylase, which
effectively converts L-histidine to histamine (Ichikawa et al., 2010).
Histamine plays an important role as an inflammatory mediator
and neurotransmitter and exerts its effects by binding to G
protein-coupled histamine receptors H1–H4 receptor with differ-
ent affinities. H1 receptor (pKi for histamine 4.2) and H2 receptor
(pKi for histamine 4.3) have long been established as histamine
receptors that are expressed in various tissues (Walter and Stark,
2012), but in the last decades, H3 receptor and H4 receptor, which
have a higher affinity for histamine (pKi 8.0 and 8.2, respectively),
have been characterized mostly in non-professional histamine-
producing cells, such as dendritic cells and lymphocytes
(Szeberenyi et al., 2001 and Kubo and Nakano, 1999). The data
obtained using HR agonists and/or antagonists have suggested that
H4 receptor is mainly involved in immunity and is expressed in
immune cells, while H3 receptor has been reported to be
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expressed in the brain and presynaptic membranes of myoneural
junctions (Zampeli and Tiligada, 2009 and Leurs et al., 2005).
H3 receptor activation with a selective agonist in the cardiac
sympathetic nerve endings reduced the rise in intracellular Ca2þ
concentration in response to membrane depolarization, while a
selective H3 receptor antagonist inhibited this effect (Silver et al.,
2002). Some studies have also found functional H3 receptor expressed
in smooth muscle cells, such as bronchial smooth muscle cells (Cardell
and Edvinsson, 1994) and bladder detrusor cells (Neuhaus et al., 2006).
However, there has been no information on H3 receptor expression in
skeletal muscle cells, myoblasts, or myotubes, and, consequently, on
the role of H3 receptor in skeletal myogenesis.
The presence and functional role of H3 receptor in smooth
muscle cells led us to hypothesize that H3 receptor may also be
expressed in skeletal muscles, where it may play a role in
cytoplasm and calcium regulation of the myotubes.
2. Materials and methods
2.1. Cell culture
Mouse C2C12 myoblasts were obtained from the Turku Center
for Biotechnology, University of Turku, Finland (Pallari et al., 2011),
and were maintained in Dulbecco's Modified Eagle's Medium
(DMEM, Lonza/BioWhittaker, Walkersville, MD, USA) supplemen-
ted with 10% fetal bovine serum (FBS; HyClone, Boston, MA, USA),
antibiotics, and L-glutamine, at 37 1C in a humidified 5% CO2
atmosphere. The differentiation medium had the same composi-
tion, except that FBS was reduced to 1%. The cells were passaged at
80% confluence using trypsinization with 0.5% trypsin in 0.5 mM
EDTA (Gibco BRL, Life Technologies, Gaithersburg, MD, USA). Three
parallel samples were cultured concurrently.
2.2. Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR)
To investigate the expression of H3 receptor during C2C12
myogenesis, 5104 cells/well were seeded in 12-well plates
(CellStar, Greiner Bio-One, Frickenhausen, Germany) in 10% FCS-
containing DMEM for 2 days. After reaching 80% confluence, cell
monolayers were switched to the differentiation medium to
induce myogenesis. Total RNA was isolated from C2C12 cells at
days 0, 2, 4, and 6 using the RNeasy Mini Kit (QIAGEN, Düsseldorf,
Germany) according to the manufacturer's instructions, and 1 μg
of total RNA was reverse-transcribed using the iScript cDNA
Synthesis Kit (BioRad Laboratories, Hercules, CA, USA). qRT-PCR
was performed with 100 ng first-strand cDNA as a template, using
iQ SYBR Green Supermix (Bio-Rad) and an iCycler iQ5 Multicolor
Real-Time PCR Detection System (Bio-Rad). Primers for the genes
encoding mouse myosin heavy chain IIa (MHC-IIa) (forward: 50-
AGCTGCACCTTCTCGTTTGCCA-30; reverse: 50-CGGTCAGGGTCGC-
TCCTGCT-30; amplicon size 261 bp), H3 receptor (forward: 50-
TTCGAGCCTCCGCACCCAGAA-30, reverse: 50-GGTCCAACGGCCGGT-
CAGC-30; amplicon size 118 bp) and porphobilinogen deaminase
(PBGD) (forward: 50-AAAGTGCCGTGGGAACCAGC-30, reverse: 50-
CAGCCACAGCCAGGACGATG-30; amplicon size 156 bp) were
designed using the NCBI Primer BLAST program. The mRNA copy
numbers in the samples were determined in triplicate and were
normalized against that of PBGD. The results were analyzed using
the comparative CT method and the expression levels of the cells
of each individual were normalized to the expression of D0.
2.3. Immunofluorescence
C2C12 cells were seeded at a density of 2104 cells/well on
coverslips in 24-well plates (Cell Star, Sigma-Aldrich, St Louis, MO,
USA) and allowed to grow in DMEM with 10% FCS for 2 days to
reach 80% confluence; then, the cells were switched to differentia-
tion medium to induce myogenesis. The cells from differentiation
days 0 and 6 were fixed in 4% paraformaldehyde in 10 mM
phosphate-buffered 140 mM saline (PBS, pH 7.4) for 15–20 min,
washed three times for 5 min in PBS and permeabilized in 0.5%
Triton X-100 in PBS for 15 min. Cells were blocked with 10%
normal donkey serum (Jackson Immunoresearch Laboratories,
Inc., West Grove, PA, USA) for 1 h and incubated at 4 1C overnight
with 1 μg/ml of primary antibodies: polyclonal affinity-purified
rabbit anti-human MHC IgG (a gift of Dr. John E. Erikson,
University of Turku, Turku, Finland) (Pallari et al., 2011), rabbit
anti-human H3 receptor polyclonal antibodies (LS-A476, MBL
International, Woburn, MA, USA), or non-immune rabbit IgG
(R&D Systems, Minneapolis, MN, USA) was used as negative
control. Cells were washed three times for 5 min in PBS and
incubated with Alexa Fluors 488-conjugated donkey anti-rabbit
IgG (Invitrogen, Carlsbad, CA, USA) diluted 1:400 in 0.1% BSA–PBS
for 1 h, washed three times for 5 min in PBS each time, and
counterstained with 40, 6-diamidino-2-phenylindole (DAPI)
(Sigma-Aldrich, St. Louis, MO, USA) diluted 1:2000 in distilled
water, for 5 min. The coverslips were washed quickly twice in PBS
and distilled water for 10 min before mounting with Vectashield
(Vector Laboratories Inc., Burlingame, CA, USA). Labeled slides
were photographed using a Leica DM 6000 B/M fluorescence
microscope equipped with a motorized Leica XY-stage and con-
nected to a Leica DFC 420 digital camera (Leica Microsystems,
Wetzlar, Germany) and analyzed using the Leica Application Suite
Advanced Fluorescence 2.5.0.6735 software.
2.4. Immunohistochemistry
The study protocol was approved by the institutional Medical
Ethics Committee and was in accord with the 1983 Declaration of
Helsinki. Informed consent was obtained from all volunteers.
The mid-urethral striated muscle samples were obtained from
three healthy male volunteers by biopsy. The samples were fixed
in 40% formaldehyde solution for 24 h and embedded in paraffin.
Paraffin blocks were sliced into 3–5-μm sections, which were
placed on the slides and incubated at 37 1C overnight. Samples
were deparaffinized by using xylene and antigens were retrieved
by heating samples in a microwave in 10 mM citrate buffer, and
were then incubated in 1% hydrogen peroxide to quench endo-
genous peroxidase activity. The samples were stained using a
VECTASTAIN Elite ABC Kit (Rabbit IgG) (PK-6101, Vector Labora-
tories, Burlingame, CA, USA). The slides were blocked in 10%
normal donkey serum for 1 h and incubated at 4 1C overnight
with 1 μg/ml of primary antibodies, viz., polyclonal affinity-
purified rabbit anti-human MHC IgG, rabbit anti-human H3 recep-
tor polyclonal antibodies, or non-immune rabbit IgG used as
negative control. The slides were washed three times for 5 min
in PBS and were then incubated with the secondary donkey anti-
rabbit IgG diluted 1:400 in 0.1% BSA–PBS for 1 h. After washing
three times for 5 min in PBS, the slides were incubated with the ABC
complex for 1 h, washed three times for 5 min in PBS, and were then
incubated in the peroxidase substrate solution until the desired
staining intensity appeared (maximum time: 10 min). The slides were
thenwashed in distilled water, counterstained in Mayer's hematoxylin,
washed in running water, dehydrated in graded ethanol, and cleared
in xylene before being mounted in Vectashield.
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2.5. Cytoplasmic Ca2þ imaging
C2C12 cells were differentiated for 7 days into myotubes on 18-
mm coverslips. The cells were then loaded with 4 mmol/L Fluo-4
AM Ca2þ indicator dye (F-14201, Invitrogen, Carlsbad, CA, USA) for
30 min at room temperature in Elliot medium, containing (mM):
137 NaCl, 5 KCl, 0.44 KH2PO4, 20 HEPES, 4.2 NaHCO3, 5 D-glucose,
2 CaCl2, 1.2 MgCl2, and 1 Na-pyruvate (pH adjusted to 7.4 with
NaOH). Then, a 30-min de-esterification was performed at 37 1C
and the coverslips were transferred to an RC-49MFS recording
chamber equipped with electrodes for field stimulation (Warner
Instruments Inc., Hamden, CT, USA) and maintained at 37 1C
during imaging.
H3 receptor agonist R-(a)-methylhistamine ((R)-α-MeHA), at
different concentrations (1 nM, 10 nM, 100 nM, 1 mM, 10 mM, and
100 mM) in Elliot medium, and a blank control (Elliot medium)
were added into parallel coverslip chambers for 5, 10, 20 min, and
30 min before electrical pacing. Ca2þ imaging in the cytoplasm
was recorded during stimulation. The cells were electrically paced
at a frequency of 0.5 Hz with 10-ms bipolar pulses (200–360 mA)
using a SIU-102 Stimulus Isolation Unit (Warner Instruments,
Hamden, CT, USA) connected to a Master-8 stimulator (A.M.P.I.,
Jerusalem, Israel). Ca2þ imaging was observed under an inverted
IX70 microscope (Olympus Corporation, Hamburg, Germany)
equipped with transparent housing, a heater, and a temperature
control unit (Solent Scientific, Ltd, Segensworth, UK) using a
UPlanSAPo 20 air objective (Olympus Corporation, Hamburg,
Germany). Polychrome IV (TILL Photonics, Graefelfing, Germany)
was used to illuminate the sample at a wavelength of 488 nm;
emitted light was filtered through a Chroma filter set (EM HQ535/
50 m, BS Q505LP, Chroma Technology Corporation, Bellows Falls,
VT, USA). Images were recorded with a Hamamatsu ORCA-Flash
4.0 sCMOS camera (Hamamatsu Photonics K.K., Hamamatsu,
Japan) at 50 frames/s. Data acquisition was controlled and the
recordings were analyzed using HC Image software (Hamamatsu
Photonics K.K., Hamamatsu, Japan). The cells for analysis were
manually selected in the regions of interest and the background
was subtracted before quantifying the fluorescence relative to
baseline fluorescence (F/F0).
2.6. Statistical analysis
All values are given as mean7standard error of the mean
(S.E.M.). Statistical differences were evaluated using the Mann–
Whitney test (Matlab, MathWorks Inc., Natick, MA, USA).
3. Results
3.1. C2C12 cell morphology during myogenesis
Before differentiation, C2C12 cells presented as mononuclear
myoblasts around 10-μm in diameter, round or spindle-like; they
were well spread and showed many contacts with the substrate
(Fig. 1A). When the cells were induced to differentiate, they started
proliferating and migrating and then arranged themselves along a
single direction to fuse into myotubes. After 6 days of differentia-
tion, the cells fused into long, multinucleated myotubes of over
150-μm in diameter (Fig. 1B).
3.2. H3 receptor expression during myogenesis and in human mid-
urethral striated muscles
The expression of H3 receptor and the late myogenesis marker
MHC during C2C12 differentiation was assessed using qRT-PCR.
MHC increased over the course of differentiation by 7168-, 89487-
Fig. 1. C2C12 cell differentiation and H3 receptor expression. C2C12 cells grown in 10% fetal calf serum (FCS)-containing DMEM were switched to 1% FCS DMEM and
differentiated for 6 days. The expression of H3 receptor and MHC (a differentiation marker) was assessed by quantitative reverse transcription-polymerase chain reaction
(qRT-PCR). (A) C2C12 myoblasts at differentiation day 0; (B) C2C12 myotubes at differentiation day 6; (C) H3 receptor expression during myogenesis at days 2, 4, and 6;
(D) MHC expression during myogenesis at days 2, 4, and 6. The scale bar represents 50 mm. Data are expressed as the mean7standard deviation (S.E.M.), and the number of
independent experiments is three; Po0.01 compared to day 0 (D0). Typically this is indicated with a *. The qRT-PCR results of the cells of each individual were normalized to
the expression at D0, and the expression of D0 is set to 1.
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and 279897-fold at days 2, 4, and 6, respectively, compared to day
0 (Fig. 1D). The expression of H3 receptor, which was initially low
in C2C12 myoblasts, also strongly increased with differentiation
when compared to day 0; by 26-, 91-, and 182-fold at days 2, 4,
and 6, respectively (Fig. 1C).
The immunofluorescence staining of the MHC protein was
negative before differentiation (Fig. 2), but was strongly positive
at day 6 (Fig. 2). Similarly, immunostaining for the H3 receptor
protein was negative at day 0 (Fig. 2), but was strongly positive at
day 6 (Fig. 2).
Human mid-urethral striated muscles showed positive immu-
nostaining for both MHC and H3 receptor proteins in the filiform-
like muscle cells (Fig. 2).
3.3. The H3 receptor agonist (R)-α-MeHA decreased cytoplasmic
Ca2þ imaging evoked by electrical stimulation
(R)-α-MeHA of different concentrations was added to stimulate
7 day-differentiated myotubes for 5, 10, and 20 min prior to
electrical pacing, and the Ca2þ imaging in the cytoplasm was
assessed during stimulation (Fig. 3). Incubation with 1 μM (R)-α-
MeHA for 10 or 20 min significantly (55%) decreased the increase
of cytoplasmic Ca2þ imaging upon electrical pacing. Shorter
(5 min) incubation with 100 nM (R)-α-MeHA decreased Ca2þ
imaging by 45%; longer treatments further increased the
decrease-effect when (R)-α-MeHA was over 100 nM. However,
(R)-α-MeHA activity in C2C12 cells displayed bell-shaped
dynamics: the concentration increase over 1 μm significantly
reduced the decrease-effect of intracellular Ca2þ imaging upon
electrical stimulation (Fig. 3). The result of (R)-α-MeHA treatment
at 30 min is not shown, because obvious decay of the Ca2þ-labeled
Fluo-4 was detected at this time.
4. Discussion
To our knowledge, this is the first investigation of the role of H3
receptor in skeletal muscle cells. When we first observed H3
receptor immunostaining in adult skeletal muscle, we hypothe-
sized that H3 receptor may play a role in skeletal myogenesis or
mature skeletal muscle cells. To test this proposal, we assessed H3
receptor expression kinetics during differentiation of mouse C2C12
myoblast cells. H3 receptor expression was almost absent in
Fig. 2. Immunostaining of H3 receptor and MHC in differentiated C2C12 cells and adult mid-urethral skeletal muscle tissues. C2C12 cells were grown in 10% FCS-containing
DMEM; the medium was then switched to 1% FCS DMEM and differentiated for 6 days. C2C12 cells and mid-urethral skeletal muscle tissues were fixed in 40% formaldehyde
solution and stained with the anti-H3 receptor antibody, anti-MHC antibody, and non-immune rabbit IgG. Upper panel: C2C12 cells, differentiation day 0 (Day 0); middle
panel: C2C12, differentiation day 6 (Day 6); lower panel: mid-urethral skeletal muscle tissues. C2C12 cells were counterstained with DAPI and mid-urethral skeletal muscle
tissues were counterstained with Mayer's hematoxylin, to reveal cell nuclei (blue). The scale bar represents 50 mm. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
Fig. 3. H3 receptor agonist decreased cytoplasmic Ca2þ imaging during electrical
stimulation in the skeletal myotubes. C2C12 myotubes, differentiated for 7 days,
were loaded with Fluo-4 AM Ca2þ indicator dye and were then incubated with the
H3 receptor agonist (R)-α-MeHA at different concentrations (1 nM, 10 nM, 100 nM,
1 μM,10 μM, 100 μM) and blank control (Elliot medium) for 5, 10, and 20 min before
electric pacing. Ca2þ imaging was performed as described in Section 2. The data are
expressed as the mean7standard deviation (S.E.M.), the number of independent
experiments is 3, and Po0.01 compared to control is indicated; typically this is
indicated with a *.It is Po0.05 compared to 5 min results; typically this is indicated
with a ♯.
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myoblasts, but increased markedly with myogenesis, suggesting
that H3 receptor mostly functions in differentiated myoblasts that
were fused into myotubes. H3 receptor functional analysis, using
an H3 receptor agonist (R)-α-MeHA, revealed that in fully differ-
entiated 7-day myotubes, H3 receptor activation decreased Ca2þ
imaging evoked by electrical stimulation. The lowest (R)-α-MeHA
concentration used (1 nM) was below the agonist affinity for H3
receptor (pKi¼8.4) in the brain (Chen et al., 2003 and Li et al.,
2014) and had no effect on the cytoplasmic Ca2þ imaging under
electrical stimulation in our study. On the other hand, the highest
(R)-α-MeHA concentration used (100 μM) was also less active,
probably because of combinatorial effects, due to nonspecific
activation of other receptors (H1 receptor or H2 receptor) on the
cell membrane (Chen et al., 2015), which counteracted the
response (Leurs et al., 1998), or probably as a self-protective
mechanism. The highest inhibitory effect of 1 μM (R)-α-MeHA,
exerted after 10- min or 20 min treatment, was in agreement with
a previous pharmacological study on histamine receptor ligands,
where (R)-α-MeHA also showed the highest efficacy at 1 μM
(Kottke et al., 2011).
The histamine receptors, including H3 receptor, are a class of G-
protein-coupled receptors. H3 receptor is coupled to the Gi/o
proteins, which have prominent effects on Ca2þ influx. H3
receptor-mediated activation of Gi/o proteins may cause the
activation of phospholipase A2 (PLA2), which induces the release
of arachidonic acid and the inhibition of the Naþ/Hþ exchanger,
leading to a decrease in intracellular Ca2þ levels involving the
impaired entrance of Ca2þ through voltage-gated ion channels
(Leurs et al., 2005). In cardiac sympathetic nerves, H3 receptor-
mediated inhibition of norepinephrine exocytosis was caused by
H3 receptor-Gi/Go coupling, and inhibition of adenylyl cyclase
activity and cAMP formation, leading to diminished protein kinase
A (PKA) activity, and decreased Ca2þ influx through voltage-
operated Ca2þ channels (Leurs et al., 2005). In our experiments,
H3 receptor activation in the differentiated C2C12 myotubes
decreased intracellular Ca2þ imaging in response to electrical
pacing, which is similar to the effect observed in cardiac sympa-
thetic nerve endings.
In mature skeletal muscle cells, the major source of Ca2þ is the
intracellular Ca2þ store in the sarcoplasmic reticulum (SR), which
accumulates Ca2þ from the cytoplasm in an ATP-dependent
manner by the action of Ca2þ-ATPase (Endo, 2009). Most of this
calcium moves back and forth across the SR membrane in cycles of
contraction and relaxation. The channel responsible for release
from the SR is the ryanodine receptor (RyR). The RyR that mediates
the efflux of Ca2þ from the SR has a central role in excitation–
contraction coupling between sarcolemmal depolarization and SR
Ca2þ release (Stokes and Wagenknecht, 2000).
In early studies of isolated frog skeletal muscles, catechola-
mines induced sarcolemmal-depolarized contraction through ele-
vation of cAMP, which also stimulates RyR on the SR, and
increased Ca2þ flux out from the SR into the cytoplasm
(Gonzalez-Serratos et al., 1981). Regulation of Ca2þ concentration
in the cytoplasm is important in coupling excitation and contrac-
tion in skeletal muscle (Emrick et al., 2010). Evidence has sug-
gested that the level of cyclic AMP may be involved in the increase
of Ca2þ in the cytoplasm (Ong and Steiner, 1977 and Lanner et al.,
2010) and is associated with contraction of both cardiac and
skeletal muscles (Gonzalez-Serratos et al., 1981). In cultured
skeletal myotubes, the activated calcitonin gene-related peptide
(CGRP) receptor can positively couple to Gs proteins and activation
of adenylate cyclase, increasing levels of cAMP generation and
subsequent protein kinase A (PKA) activation to increase contrac-
tion force. During this process, CGRP increases voltage-gated SR
Ca2þ release within hours, resulting from a quantitatively similar
increase in releasable SR Ca2þ content (Avila et al., 2007). When
chicken and rat skeletal muscle cells were cultured for 7 days and
were then subjected to electrical stimulation for additional 2 days,
the ability of these cells to synthesize cAMP was increased by
almost two-fold (Young et al., 2000). In our study, electrical
stimulation of differentiated C2C12 myotubes may have caused
upregulation of cAMP biosynthesis; in this case, H3 receptor
activation may inhibit cAMP elevation and prevent over-
contraction. Other studies found histidine decarboxylase activity
was very low in normal non exercised muscle (Endo et al., 1998)
and mice treated with a H3 receptor antagonist display no
significant effects on prolonged walking endurance (Niijima-
Yaoita et al., 2012), suggesting that histamine and H3 receptor
signaling have a limited role on normal muscle physiology. It is the
possibility that H3 receptor is activated only in exercised and/or
excited muscle. In addition, we also tried ciproxifan (histamine H3-
receptor antagonist, pKi¼9.1–9.4) 1 μM instead of (R)-α-MeHA to
do the experiment, and found there was no cytoplamic Ca2þ
imaging arise compare to the control. So H3 receptor blockage
might not enhance cell contraction.
In conclusion, we found that the histamine H3 receptor agonist
(R)-α-MeHA can attenuate cytoplasmic Ca2þ imaging during
electrical stimulation in differentiated C2C12 myotubes, which
may facilitate relaxation of cells and prevent over-contraction in
electrically stimulated C2C12 myotubes. Attenuation of the cyto-
plasmic Ca2þ imaging may occur via activation of H3 receptor to
induce inhibition of cAMP formation, or activation of PLA2, release
of arachidonic acid, and the subsequent decrease in intracellular
Ca2þ levels. These effects are most prominent early during
myotube maturation. Whether these effects also occur in muscle
regeneration remains to be elucidated.
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